| Name | Dock Terrace |
|---|---|
| Location | 275 Dock Drive, Lansdale, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 72 |
| Occupancy Rate | 77.92% |
| Medicare ID (CCN) | 395557 |
| Legal Business Name | Hatfield Mennonite Home |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study being presented at the annual meeting of the American Society of Hematology by researchers at Dana-Farber Cancer Institute.
Ischemic stroke takes a holiday on Sunday but returns with a vengeance on Monday, particularly in the elderly who are poor and less educated, according to a Finnish study.
ADVENTRX Pharmaceuticals, Inc. today announced that a new, recently completed preclinical study has affirmed the bioequivalence and comparable toxicity of ANX-514 and Taxotere® (docetaxel). Shin Poong Pharmaceuticals, ADVENTRX's partner for ANX-514 in South Korea, independently conducted the study and data analysis.
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.
Autism Speaks, the world's leading autism science and advocacy organization, today announced it has awarded more than $600,000 in funding for six promising scientists pursuing academic training in translational research.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 6.1 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.42 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 68.6 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.07 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.54 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.64 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.53 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.02 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 22.34 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.31 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 15.9 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 32.74 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.35 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.62 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 77.56 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 97.2 | 82.93 |
News Archive
The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study being presented at the annual meeting of the American Society of Hematology by researchers at Dana-Farber Cancer Institute.
Ischemic stroke takes a holiday on Sunday but returns with a vengeance on Monday, particularly in the elderly who are poor and less educated, according to a Finnish study.
ADVENTRX Pharmaceuticals, Inc. today announced that a new, recently completed preclinical study has affirmed the bioequivalence and comparable toxicity of ANX-514 and Taxotere® (docetaxel). Shin Poong Pharmaceuticals, ADVENTRX's partner for ANX-514 in South Korea, independently conducted the study and data analysis.
Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.
Autism Speaks, the world's leading autism science and advocacy organization, today announced it has awarded more than $600,000 in funding for six promising scientists pursuing academic training in translational research.
› Verified 3 days ago
Harborview Rehabilitation And Care Center At Lansd Location: 25 West Fifth Street, Lansdale, Pennsylvania 19446 Phone: (215) 855-9765 | |
Gwynedd Healthcare And Rehabilitation Center Location: 773 Sumneytown Pike, Lansdale, Pennsylvania 19446 Phone: (215) 699-5000 | |
Elm Terrace Gardens Location: 660 North Broad Street, Lansdale, Pennsylvania 19446 Phone: (215) 361-5600 | |
St Mary Center For Rehabilitation & Healthcare Location: 701 Lansdale Avenue, Lansdale, Pennsylvania 19446 Phone: (215) 368-0900 | |
Willowbrooke Court Skilled Care Center At Brittany Location: 1001 Valley Forge Road, Lansdale, Pennsylvania 19446 Phone: (215) 855-9700 |